Abstract
For a given mutation status, we define the absolute risk as the chance that disease develops in a defined age interval, given that the person is well at the beginning of the interval. Absolute risk is reduced by competing risks of mortality, that may cause the person to die before the disease of interest develops. We distinguish absolute risk from the pure cumulative risk of disease that is often estimated in the genetic epidemiologic literature, and we concentrate on estimating marginal risks for members selected at random from the population, rather than family specific risks. We review cohort, population-based case–control, case–control family, and kin-cohort designs for estimating absolute and pure cumulative risks associated with a measurable genetic mutation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson P, Borgen O, Gill R, Keiding N (1991) Statistical Models based on counting processes. Springer-Verlag, New York
Begg C (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221–1226
Benichou J, Gail M (1990) Estimates of absolute cause-specific risk in cohort studies. Biometrics 46:813–826
Benichou J, Gail M (1995) Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics 51:182–194
Chatterjee N, Wacholder S (2001) A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics 57:245–252
Chatterjee N, Hartge P, Wacholder S (2003) Adjustment for competing risk in kin-cohort estimation. Genetic Epidemiol 25:303–313
Chatterjee N, Kalaylioglu Z, Shih J, Gail M (2006) Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk. Biometrics 62:36–48
Claus E, Risch N, Thompson W (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Human Genetics 48:232–242
Claus E, Risch N, Thompson W (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications and risk prediction. Cancer 73:643–651
Clayton DG (1978) A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65:141–151
Cornfield J (1951) A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst 11:1269–1275
Ford D, Easton D, Stratton M, Narod S, Goldar D, Devilee P, Bishop D, Weber B, Lenoir G, Chang-Claude J, et al (1998) Genetic heterogeneity and penetrance analysis of the brca1 and brca2 genes in breast cancer families. the breast cancer linkage consortium. Am J Human Genetics 62:676–689
Gail M, Chatterjee N (2004) Some biases that may affect kin-cohort studies for estimating the risks from identified disease genes. Springer, New York
Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C, Mulvihill J (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886
Gail M, Constantino J, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V (1999a) Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91:1829–1846
Gail M, Pee D, Benichou J, Carroll R (1999b) Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs. Genetic Epidemiol 16:15–39
Gail M, Pee D, Carroll R (1999c) Kin-cohort designs for gene characterization. J Natl Cancer Inst Monogr 26:55–60
Gail M, Pee D, Carroll R (2001) Effects of violations of assumptions on likelihood methods for estimating the penetrance of an autosomal dominant mutation from kin-cohort studies. J Stat Plan Infer 96:167–177
Genest C, Mackay R (1986) The joy of copulas: bivariate distributions with given marginals. Am Stat 40:280–283
Hooper J, Southey M, Dite G, Jolley D, Giles G, McGredie M, Venter DED (1990) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in brca1 and brca2. Australian breast cancer family study. Am J Human Genetics 8:813–826
Hsu L, Prentice R, Zhao L, Fan J (1999) On dependence estimation using correlated failure time data from case-control family studies. Biometrika 86:743–753
Langholz B, Goldstein L (1996) Estimation of absolute risk from nested case-control data. Biometrics 53:767–774
Li H (1998) Analysis of age of onset data from case-control family studies. Biometrics 54:1030–1039
Liang K, Zeger S, Qaqish B (1992) Multivariate regression-analyses for categorical-data. J Royal Stat Soc Ser B 54:3–40
Moore D, Chatterjee N, Pee D, Gail M (2001) Pseudo-likelihood estimates of the cumulative risk of an autosomal dominant disease from a kin-cohort study. Genetic Epidemioly 20: 210–227
Oakes D (1989) Bivariate survival models induced by frailties. J Am Stat Assoc 84:487–493
Prentice R, Pyke R (1979) Logistic disease incidence models and case-control studies. Biometrika 66:403–411
Prentice R, Kalbfleisch J, Jr AP, Flournoy N, Farewell V, Breslow N (1978) The analysis of failure times in the presence of competing risks. Biometrics 34:541–554
Self S, Prentice R (1988) Asymptotic distribution theory and efficiency results for case-cohort studies. Ann Statistics 16:64–81
Shih J, Chatterjee N (2002) Analysis of survival data from case-control family studies. Biometrics 54:1115–1128
Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M, Timmerman M, Brody L, Tucker M (1997) The risk of cancer associated with specific mutations of brca1 and brca2 among ashkenazi jews. New Engl J Med 336:1401–1408
Wacholder S, Hartge P, Struewing J, Pee D, McAdams M, Brody L, Tucker M (1998) The kin-cohort study for estimating penetrance. Am J Epidemiol 148:623–630
Whittemore A (1995) Logistic regression of family data from case-control studies. Biometrika 82:57–67
Zhao L, Hsu L, Holte S, Chen Y, Quiaoit F, Prentice R (1998) Combined association and aggregation analysis of data from case-control family studies. Biometrika 85:299–315
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gail, M.H., Chatterjee, N. (2009). Estimating the Absolute Risk of Disease Associated with Identified Mutations. In: Handbook on Analyzing Human Genetic Data. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69264-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-69264-5_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69263-8
Online ISBN: 978-3-540-69264-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)